Andrew Christie
Director/Board Member at HELIOS UNDERWRITING PLC
Net worth: 77 441 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Libassi | M | 66 | 3 years | |
| Ben Mingay | M | 58 |
Smith Square Partners LLP
 Smith Square Partners LLP Investment ManagersFinance Smith Square Partners LLP provides corporate finance advisory services. It offers its services to corporations, private equity firms, investors and entrepreneurs. The firm specializes in public company takeovers, company acquisitions and sales, advising on capital markets transactions, refinancing and restructuring, and management advice. The company was founded by Benjamin Edward Mingay in 2010 and is headquartered in London, the United Kingdom. | 14 years |
| Arthur Manners | M | 65 | 9 years | |
| Nigel Hanbury | M | 67 | 12 years | |
| Paul Waterman | M | 60 | 8 years | |
| Martin Reith | M | 59 | 3 years | |
| Ralph Hewins | M | 61 | 8 years | |
| Dorothée Anna Deuring | F | 55 | 7 years | |
| Michael J. Wade | M | 82 | 1 years | |
| Alexander Phillips | M | 54 |
Smith Square Partners LLP
Smith Square Partners LLP Investment ManagersFinance Smith Square Partners LLP provides corporate finance advisory services. It offers its services to corporations, private equity firms, investors and entrepreneurs. The firm specializes in public company takeovers, company acquisitions and sales, advising on capital markets transactions, refinancing and restructuring, and management advice. The company was founded by Benjamin Edward Mingay in 2010 and is headquartered in London, the United Kingdom. | - |
| Martha Bruce | F | - | 10 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Harold Cunningham | M | 77 | - | |
| Ian Brindle | M | 80 | 9 years | |
| Andrew Duff | M | 65 | 7 years | |
| Brian G. Taylorson | M | 68 | 14 years | |
| Anne Philomena Hyland | F | 64 | 9 years | |
| Wolfgang Plischke | M | 72 |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 7 years |
| Steve Good Good | M | 63 | 10 years | |
| Jeremy Evans | M | 66 | 14 years | |
| Robert G. Beeston | M | 82 | 7 years | |
| Edward Fitzalan-Howard | M | 68 | 6 years | |
| David W. Dutro | M | 68 | 18 years | |
| Nick Salmon Salmon | M | 72 | 6 years | |
| David Philip Bloxham | M | - |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 4 years |
| Kevin Roger Kenneth Matthews | M | 60 | 9 years | |
| Christopher Girling | M | 70 | 8 years | |
| Sandra Lynne Boss | F | 57 | 3 years | |
| Ken Morris | M | - | - | |
| Ken Smith | M | - | - | |
| Wendi Weber | M | - | 2 years | |
| Robert Sklans | M | - | 2 years | |
| Rob Mangold | M | - | - | |
| Dennis Turner | M | - |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 10 years |
| Brad Rector | M | - | - | |
| Russell Banks | M | - |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | - |
| David Bowyer | M | - |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 7 years |
| Paul Lumbis | M | - | 3 years | |
| James Michael Yorrick Oliver | M | 83 | - | |
| Nigel Richard Parker | M | - |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 13 years |
| Mark H. Richmond | M | 93 |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 13 years |
| Iain Ross | M | 71 |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 5 years |
| Greg Bellotti | M | - | 9 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 42 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Andrew Christie
- Personal Network
